vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and TRICO BANCSHARES (TCBK). Click either name above to swap in a different company.
TRICO BANCSHARES is the larger business by last-quarter revenue ($109.4M vs $85.1M, roughly 1.3× 4D Molecular Therapeutics, Inc.). TRICO BANCSHARES runs the higher net margin — 251.6% vs 22.8%, a 228.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 9.0%). TRICO BANCSHARES produced more free cash flow last quarter ($127.9M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 5.4%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Trico Bancshares is a U.S.-headquartered regional bank holding company operating Tri Counties Bank. It offers a full range of retail and commercial banking services including deposit products, mortgages, small business loans, and wealth management, primarily serving consumers and SMEs in Northern California.
FDMT vs TCBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $109.4M |
| Net Profit | $19.4M | $33.6M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 42.6% |
| Net Margin | 22.8% | 251.6% |
| Revenue YoY | 8508900.0% | 9.0% |
| Net Profit YoY | 139.1% | 15.8% |
| EPS (diluted) | $0.43 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $109.4M | ||
| Q3 25 | $90.0K | $107.6M | ||
| Q2 25 | $15.0K | $103.6M | ||
| Q1 25 | $14.0K | $98.6M | ||
| Q4 24 | $1.0K | $100.4M | ||
| Q3 24 | $3.0K | $99.1M | ||
| Q2 24 | $5.0K | $97.9M | ||
| Q1 24 | $28.0K | $98.5M |
| Q4 25 | $19.4M | $33.6M | ||
| Q3 25 | $-56.9M | $34.0M | ||
| Q2 25 | $-54.7M | $27.5M | ||
| Q1 25 | $-48.0M | $26.4M | ||
| Q4 24 | — | $29.0M | ||
| Q3 24 | $-43.8M | $29.1M | ||
| Q2 24 | $-35.0M | $29.0M | ||
| Q1 24 | $-32.4M | $27.7M |
| Q4 25 | 17.3% | 42.6% | ||
| Q3 25 | -67983.3% | 43.2% | ||
| Q2 25 | -396373.3% | 36.5% | ||
| Q1 25 | -383007.1% | 35.8% | ||
| Q4 24 | — | 38.7% | ||
| Q3 24 | -1704400.0% | 39.8% | ||
| Q2 24 | -849120.0% | 40.0% | ||
| Q1 24 | -136200.0% | 38.3% |
| Q4 25 | 22.8% | 251.6% | ||
| Q3 25 | -63195.6% | 31.6% | ||
| Q2 25 | -364386.7% | 26.6% | ||
| Q1 25 | -342657.1% | 26.7% | ||
| Q4 24 | — | 221.4% | ||
| Q3 24 | -1461433.3% | 29.3% | ||
| Q2 24 | -699060.0% | 29.7% | ||
| Q1 24 | -115717.9% | 28.2% |
| Q4 25 | $0.43 | $1.02 | ||
| Q3 25 | $-1.01 | $1.04 | ||
| Q2 25 | $-0.98 | $0.84 | ||
| Q1 25 | $-0.86 | $0.80 | ||
| Q4 24 | — | $0.88 | ||
| Q3 24 | $-0.79 | $0.88 | ||
| Q2 24 | $-0.63 | $0.87 | ||
| Q1 24 | $-0.66 | $0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $157.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $1.3B |
| Total Assets | $566.7M | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $157.0M | ||
| Q3 25 | $305.1M | $298.8M | ||
| Q2 25 | $293.2M | $314.3M | ||
| Q1 25 | $321.4M | $308.3M | ||
| Q4 24 | $424.9M | $145.0M | ||
| Q3 24 | $501.9M | $320.1M | ||
| Q2 24 | $541.9M | $206.6M | ||
| Q1 24 | $525.9M | $82.8M |
| Q4 25 | $505.7M | $1.3B | ||
| Q3 25 | $369.0M | $1.3B | ||
| Q2 25 | $420.9M | $1.3B | ||
| Q1 25 | $469.7M | $1.3B | ||
| Q4 24 | $510.6M | $1.2B | ||
| Q3 24 | $552.9M | $1.2B | ||
| Q2 24 | $588.3M | $1.2B | ||
| Q1 24 | $600.6M | $1.2B |
| Q4 25 | $566.7M | $9.8B | ||
| Q3 25 | $424.0M | $9.9B | ||
| Q2 25 | $473.6M | $9.9B | ||
| Q1 25 | $515.7M | $9.8B | ||
| Q4 24 | $560.4M | $9.7B | ||
| Q3 24 | $604.0M | $9.8B | ||
| Q2 24 | $620.1M | $9.7B | ||
| Q1 24 | $629.9M | $9.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $133.3M |
| Free Cash FlowOCF − Capex | $28.5M | $127.9M |
| FCF MarginFCF / Revenue | 33.5% | 116.9% |
| Capex IntensityCapex / Revenue | 0.1% | 4.9% |
| Cash ConversionOCF / Net Profit | 1.47× | 3.96× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $222.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $133.3M | ||
| Q3 25 | $-46.5M | $45.1M | ||
| Q2 25 | $-43.4M | $29.2M | ||
| Q1 25 | $-47.8M | $24.5M | ||
| Q4 24 | $-134.6M | $109.7M | ||
| Q3 24 | $-29.4M | $28.6M | ||
| Q2 24 | $-30.2M | $31.8M | ||
| Q1 24 | $-29.1M | $25.1M |
| Q4 25 | $28.5M | $127.9M | ||
| Q3 25 | $-46.6M | $43.2M | ||
| Q2 25 | $-43.4M | $28.2M | ||
| Q1 25 | $-48.4M | $22.8M | ||
| Q4 24 | $-138.4M | $105.2M | ||
| Q3 24 | $-31.2M | $27.3M | ||
| Q2 24 | $-30.6M | $30.8M | ||
| Q1 24 | $-29.8M | $24.1M |
| Q4 25 | 33.5% | 116.9% | ||
| Q3 25 | -51765.6% | 40.2% | ||
| Q2 25 | -289620.0% | 27.2% | ||
| Q1 25 | -345635.7% | 23.1% | ||
| Q4 24 | -13837100.0% | 104.8% | ||
| Q3 24 | -1038966.7% | 27.6% | ||
| Q2 24 | -611840.0% | 31.5% | ||
| Q1 24 | -106421.4% | 24.4% |
| Q4 25 | 0.1% | 4.9% | ||
| Q3 25 | 101.1% | 1.7% | ||
| Q2 25 | 440.0% | 1.0% | ||
| Q1 25 | 4507.1% | 1.7% | ||
| Q4 24 | 378600.0% | 4.5% | ||
| Q3 24 | 59266.7% | 1.3% | ||
| Q2 24 | 6980.0% | 1.0% | ||
| Q1 24 | 2535.7% | 1.0% |
| Q4 25 | 1.47× | 3.96× | ||
| Q3 25 | — | 1.33× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | — | 3.78× | ||
| Q3 24 | — | 0.98× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
